Use of IVUS Imaging in PCI of Left Main Coronary Artery Disease
Prof. Adrian Banning (John Radcliffe Hospital, Oxford, UK) presents this webinar on the use of IVUS imaging in percutaneous coronary intervention (PCI) of Left Main Coronary Artery Disease.
This webinar is intended to educate interventional cardiologists, interventional fellows and related healthcare professionals, and discusses and analyses the role of intravascular imaging with intravascular ultrasound in LMCA PCI, focusing on the main applications in this context from lesion assessment to stent sizing and optimisation.
The webinar/clinical case scenarios will:
- Provide the background for LMCA disease and its treatment, including findings from the SYNTAX study comparing the use of CABG and PCI interventions in the LMCA setting
- Highlight the role and recommended use of IVUS in interventions for LMCA, including rationale for its use versus coronary angiography
- Definition of when to use IVUS as determined by validated MLA cut-off values
- Outline of the use of IVUS imaging for characterisation of LMCA disease and to facilitate stent sizing and stent optimisation
- Discuss real-life case studies describing IVUS in ostial left main disease and bifurcation left main disease
- Present a workflow algorithm to guide the operator, in a step-wise manner, on the use of IVUS applications in the LMCA setting
Adrian P Banning
This webinar is supported by:
This webinar is to inform and educate interventional cardiologists and cardiologists on:
- Interventions historically and currently used for the treatment of LMCA disease
- The role of IVUS imaging in LMCA interventions
- When IVUS imaging should be used and the benefits of its use
- A workflow algorithm developed to facilitate operators in using IVUS imaging in the LMCA setting
- Interventional Cardiologists
- Interventional Fellows
- Cathlab Nurses Technicians and Managers
Adrian P Banning
Dr Adrian Banning is a consultant cardiologist specialising in percutaneous coronary intervention.
He is the president of the British Cardiac Intervention Society and was previously the Divisional Director for Cardiology, Cardiothoracic and Vascular Surgery at the John Radcliffe University Hospital, Oxford. Through his position at the John Radcliffe, and his own practice at Oxford’s The Manor Hospital, Prof Banning provides specialist regional services for coronary and valvular heart disease patients to an area of 1.2 million people.
Prof Banning is pioneering research in his field and lectures nationally and internationally. He has authored several books on coronary intervention and has more than 300 PubMed listed scientific papers to his name.
1. Morice MC, et al. Circulation 2010;121:2645–53
2. Windecker S, et al. Eur Heart J 2014;35:2541–619
3. Campos CM, et al. EuroIntervention 2015;11 Suppl V:115–9
4. Jasti V, et al. Circulation 2004;110:2831–6
5. de la Torre Hernandez JM, et al. J Am Coll Cardiol 2011;58:351–8
6. Kang SJ, et al. Catheter Cardiovasc Interv 2014;83:545–52
7. Tuzcu EM, et al. J Am Coll Cardiol 1996;27:832–8
8. Mintz GS, et al. Circulation 1995;91:1959–65